Страна: Нідерланди
мова: голландська
Джерело: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
ETHINYLESTRADIOL 0,02 mg/stuk ; GESTODEEN 0,075 mg/stuk
Laboratorios Leon Farma, S.A. C/La Vallina s/n, Pol. Ind. 24008 NAVATEJERA (SPANJE)
G03AA10
ETHINYLESTRADIOL 0,02 mg/stuk ; GESTODEEN 0,075 mg/stuk
Tablet
CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; POLACRILINE KALIUM ; POVIDON K 30 (E 1201), CELLULOSE, MICROKRISTALLIJN (E 460) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; POLACRILINE KALIUM ; POVIDON K 30 (E 1201),
Oraal gebruik
Gestodene And Ethinylestradiol
Hulpstoffen: CELLULOSE, MICROKRISTALLIJN (E 460); LACTOSE 1-WATER; MAGNESIUMSTEARAAT (E 470b); POLACRILINE KALIUM; POVIDON K 30 (E 1201);
1900-01-01
B. PACKAGE LEAFLET 1 LF-GSTDEE-NL-NL.H.2962.001.IB.019-D0 2 PACKAGE LEAFLET: INFORMATION FOR THE USER MARYNARKA 0,075 MG/ 0,020 MG TABLETTEN Gestodene / Ethinylestradiol IMPORTANT THINGS TO KNOW ABOUT COMBINED HORMONAL CONTRACEPTIVES (CHCS): • They are one of the most reliable reversible methods of contraception if used correctly • They slightly increase the risk of having a blood clot in the veins and arteries, especially in the first year or when restarting a combined hormonal contraceptive following a break of 4 or more weeks • Please be alert and see your doctor if you think you may have symptoms of a blood clot (see section 2 “Blood clots”) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. -Keep this leaflet. You may need to read it again. -If you have any further questions or need more advice, ask your doctor, family planning nurse, or pharmacist. -This medicine has been prescribed for you only. Do not pass it on to others. It may harm them. -If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this lealfet. See section 4. WHAT IS IN THIS LEAFLET 1. What Marynarka is and what it is used for 2. What you need to know before you take Marynarka 3. How to take Marynarka 4. Possible side effects 5. How to store Marynarka 6. Contents of the pack and other information 1. WHAT MARYNARKA IS AND WHAT IT IS USED FOR • Marynarka is a contraceptive tablet and is used to prevent pregnancy. • Each tablet contains a small amount of two different female hormones, namely ethinylestradiol and gestodene. • Contraceptive tablets as Marynarka that contain two hormones are called “combination” contraceptives. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MARYNARKA GENERAL NOTES BEFORE YOU START USING MARYNARKA YOU SHOULD READ THE INFORMATION ON BLOOD CLOTS IN SECTION 2. IT IS PARTICULARLY IMPORTANT TO READ THE SYMPTOMS OF A BLOOD CLOT – SEE SECTION 2 “BLOOD CLOTS” Before yo Прочитайте повний документ
SPC-GSTDEE-NL-NL.H.2962.001.IA.021-D0 1 SUMMARY OF PRODUCT CHARACTERISTICS SPC-GSTDEE-NL-NL.H.2962.001.IA.021-D0 2 1. NAME OF THE MEDICINAL PRODUCT Marynarka 0,075 mg/0,020 mg tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each white tablet contains 0,075 mg gestodene and 0,020 mg ethinylestradiol Excipients with known effect: Each tablet contains 59.12 mg lactose monohydrate. For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablets. Round, white tablets, with a diameter of 5.7 mm approximately. The white tablet is debossed with a ‘ _C’ _ on one side and ‘ _34’ _ on the other side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Oral contraception. The decision to prescribe Marynarka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Marynarka compares with other CHCs (see sections 4.3 and 4.4). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration: oral use HOW TO TAKE MARYNARKA The tablets must be taken every day at approximately the same time, if necessary with a little liquid, in the order indicated on the blister pack. One tablet per day should be taken for 21 days. Each subsequent pack should be started after a 7-day tablet-free interval during which time a withdrawal bleeding will occur. This bleeding usually starts on the 2 nd or 3 rd day after taking the last tablet, and may not stop until the next pack is started. HOW TO START TAKING MARYNARKA • If no preceding hormonal contraceptive use in the past month Taking of the tablets should begin on the first day of the woman’s natural cycle (i.e. on the first day of the woman’s menstrual bleeding). One may begin taking the pills on day 2-5, but in these cases, it is recommended that a barrier method also be used for the first 7 days on which pills are taken during the first cycle. • Changing from a combined hormonal contraceptive (combined oral contraceptive (COC), vaginal ring, or transderm Прочитайте повний документ